Current and historical daily PE Ratio for 4d pharma PLC (
LSE:DDDD
) from 2014 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. 4d pharma PLC stock (LSE:DDDD) PE ratio as of Jun 05 2024 is 0.
More Details
4d pharma PLC (LSE:DDDD) PE Ratio (TTM) Chart
4d pharma PLC (LSE:DDDD) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 944
- 1
- 2
- 3
- 4
- 5
- 6
- 11
| 4d pharma PLC PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-05 | At Loss | 2022-12-08 | At Loss |
| 2023-02-14 | At Loss | 2022-12-07 | At Loss |
| 2023-02-13 | At Loss | 2022-12-06 | At Loss |
| 2023-02-10 | At Loss | 2022-12-05 | At Loss |
| 2023-02-09 | At Loss | 2022-12-02 | At Loss |
| 2023-02-08 | At Loss | 2022-12-01 | At Loss |
| 2023-02-07 | At Loss | 2022-11-30 | At Loss |
| 2023-02-06 | At Loss | 2022-11-29 | At Loss |
| 2023-02-03 | At Loss | 2022-11-28 | At Loss |
| 2023-02-02 | At Loss | 2022-11-25 | At Loss |
| 2023-02-01 | At Loss | 2022-11-24 | At Loss |
| 2023-01-30 | At Loss | 2022-11-23 | At Loss |
| 2023-01-27 | At Loss | 2022-11-22 | At Loss |
| 2023-01-26 | At Loss | 2022-11-21 | At Loss |
| 2023-01-25 | At Loss | 2022-11-18 | At Loss |
| 2023-01-24 | At Loss | 2022-11-17 | At Loss |
| 2023-01-23 | At Loss | 2022-11-16 | At Loss |
| 2023-01-20 | At Loss | 2022-11-15 | At Loss |
| 2023-01-19 | At Loss | 2022-11-14 | At Loss |
| 2023-01-18 | At Loss | 2022-11-11 | At Loss |
| 2023-01-17 | At Loss | 2022-11-10 | At Loss |
| 2023-01-16 | At Loss | 2022-11-09 | At Loss |
| 2023-01-13 | At Loss | 2022-11-08 | At Loss |
| 2023-01-12 | At Loss | 2022-11-07 | At Loss |
| 2023-01-11 | At Loss | 2022-11-04 | At Loss |
| 2023-01-10 | At Loss | 2022-11-03 | At Loss |
| 2023-01-09 | At Loss | 2022-11-02 | At Loss |
| 2023-01-06 | At Loss | 2022-11-01 | At Loss |
| 2023-01-05 | At Loss | 2022-10-28 | At Loss |
| 2023-01-04 | At Loss | 2022-10-27 | At Loss |
| 2023-01-03 | At Loss | 2022-10-26 | At Loss |
| 2022-12-30 | At Loss | 2022-10-25 | At Loss |
| 2022-12-29 | At Loss | 2022-10-24 | At Loss |
| 2022-12-28 | At Loss | 2022-10-21 | At Loss |
| 2022-12-23 | At Loss | 2022-10-20 | At Loss |
| 2022-12-22 | At Loss | 2022-10-19 | At Loss |
| 2022-12-21 | At Loss | 2022-10-18 | At Loss |
| 2022-12-20 | At Loss | 2022-10-17 | At Loss |
| 2022-12-19 | At Loss | 2022-10-14 | At Loss |
| 2022-12-16 | At Loss | 2022-10-13 | At Loss |
| 2022-12-15 | At Loss | 2022-10-12 | At Loss |
| 2022-12-14 | At Loss | 2022-10-11 | At Loss |
| 2022-12-13 | At Loss | 2022-10-10 | At Loss |
| 2022-12-12 | At Loss | 2022-10-07 | At Loss |
| 2022-12-09 | At Loss | 2022-10-06 | At Loss |
4d pharma PLC (LSE:DDDD) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
4d pharma PLC
ISIN : GB00BJL5BR07
Compare
Compare
Traded in other countries / regions
4DY.GermanyDDDD.UK IPO Date
2014-02-18Description
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers